Michael Gent

53.9k citations
231 papers · 34.9k · 21 hit papers · h-index 90

Impact in

    • Venous Thromboembolism Diagnosis and Management
    • Atrial Fibrillation Management and Outcomes
    • Cardiac pacing and defibrillation studies
    • Antiplatelet Therapy and Cardiovascular Diseases
    • Acute Myocardial Infarction Research
    • Cardiac Arrhythmias and Treatments

Papers in

    • Atrial Fibrillation Management and Outcomes 39
    • Antiplatelet Therapy and Cardiovascular Diseases 38
    • Cardiac pacing and defibrillation studies 20
    • Acute Myocardial Infarction Research 16
    • Cardiac Arrhythmias and Treatments 8
    • Venous Thromboembolism Diagnosis and Management 92

Michael Gent

226 papers receiving 32.5k citations

Michael Gent's Hit Papers

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial 2009 · 741 citations
7410+12+24Years since publication50010001.5k2.0k

Peers

Michael Gent
Comparison fields: 5 of 180
  • Internal Medicine 13.6k
  • Cardiology and Cardiovascular Medicine 16.4k
  • Hematology 4.3k
  • Emergency Medical Services 1.8k
  • Surgery 7.3k
Replace Samuel Z. Goldhaber with:
Samuel Z. Goldhaber United States
Jack Hirsh Canada
Mark Crowther Canada
David Bergqvist Sweden
Sam Schulman Canada
John W. Eikelboom Canada
Martin H. Prins Netherlands
John A. Heit United States
Harry R. Büller Netherlands
Frits R. Rosendaal Netherlands
Michael Gent relative to Samuel Z. Goldhaber United States Samuel Z. Goldhaber's profile →
Citations per field
00.5×1.5×
Samuel Z. Goldhaber · 1×
Citations per year

Countries citing papers authored by Michael Gent

Since Specialization
Citations

This map shows the geographic impact of Michael Gent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gent more than expected).

Fields of papers citing papers by Michael Gent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gent. The network helps show where Michael Gent may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Gent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Gent Line = papers co-authored together Michael Gent links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 231 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Intra-arterial Prourokinase for Acute Ischemic Stroke
Hit paper breakdown →
19992206
2
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
Hit paper breakdown →
20031811
3
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
Hit paper breakdown →
19951699
4
Canadian Implantable Defibrillator Study (CIDS)
Hit paper breakdown →
20001037
5
Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction
Hit paper breakdown →
2004899
6
PROACT: A Phase II Randomized Trial of Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute Middle Cerebral Artery Stroke
Hit paper breakdown →
1998897
7
A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis
Hit paper breakdown →
1996872
8
Canadian atrial fibrillation anticoaguiation (CAFA) study
Hit paper breakdown →
1991831
9
Aspirin, Sulfinpyrazone, or Both in Unstable Angina
Hit paper breakdown →
1985773
10
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
Hit paper breakdown →
2009741
11
Platelet-Active Drugs
Hit paper breakdown →
2001714
12
THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE
Hit paper breakdown →
1989616
13
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT
Hit paper breakdown →
1997607
14
A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome
Hit paper breakdown →
2003600
15
Incidence of Recurrent Thromboembolic and Bleeding Complications Among Patients With Venous Thromboembolism in Relation to Both Malignancy and Achieved International Normalized Ratio: A Retrospective Analysis
Hit paper breakdown →
2000558
16
Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein Thrombosis
Hit paper breakdown →
1986557
17
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis
Hit paper breakdown →
1982556
18
Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism
Hit paper breakdown →
2003546
19 2000483
20
Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis
Hit paper breakdown →
1979456

About Michael Gent

Michael Gent is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Surgery, Hematology and Epidemiology, having authored 231 papers that have together received 34.9k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (92 papers), Atrial Fibrillation Management and Outcomes (39 papers), Antiplatelet Therapy and Cardiovascular Diseases (38 papers), Cardiac pacing and defibrillation studies (20 papers), Acute Ischemic Stroke Management (19 papers), Blood Coagulation and Thrombosis Mechanisms (16 papers), Acute Myocardial Infarction Research (16 papers) and Cardiac Arrhythmias and Treatments (8 papers). The work is most often cited by research in Internal Medicine (13.6k citations), Cardiology and Cardiovascular Medicine (16.4k citations), Hematology (4.3k citations), Emergency Medical Services (1.8k citations) and Surgery (7.3k citations). Michael Gent has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Jack Hirsh, Stuart J. Connolly, Robin S. Roberts, Mark N. Levine, John A. Cairns, Jim A. Julian, David L. Sackett, Howard A. Rowley, Randall T. Higashida and J. Hirsh. Their work appears in journals such as New England Journal of Medicine, Circulation, Thrombosis and Haemostasis, Thrombosis Research and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact